Comparing the current results to its competitors, 908 Devices Inc reported Revenue increase in the 2 quarter 2026 by 29.91 % year on year. The sales growth was above 908 Devices Inc 's competitors' average revenue growth of 8.31 %, achieved in the same quarter.
908 Devices Inc 's Comment on Competition and Industry Peers
The company operates in a competitive market that includes both small privately held firms and large publicly held corporations specializing in mass spectrometry and spectroscopy products. Named competitors include Agilent, Bruker, Danaher, Inficon, Teledyne, Rigaku, and Thermo Fisher Scientific. Many of these competitors possess greater resources and a larger market presence. The market is characterized by rapid technological advancements and changing customer requirements.
June 18, 2024
In the ever-evolving landscape of chemical analysis, 908 Devices Inc. (Nasdaq: MASS), a leader in developing handheld and desktop devices for chemical identification and analysis, has carved out a significant niche for itself. The company s latest move seeks to bolster its position further through technological enhancements to one of its key products, the XplorIR portable analyzer. Technological Enhancements: XplorIR Gas and Vapor Analyzer908 Devices announced an enhanced quantification package for XplorIR, their handheld gas and vapor analyzer, which initially entered the market following the company s acquisition of RedWave Technology. This update will empower the device to quantify nearly 5,000 airborne c...
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Bruker Corporation operates as a manufacturer and supplier of scientific instruments and analytical solutions for a wide range of industries and research fields.
Digital Brand Media And Marketing Group Inc Share Performance
-9.09%
Over The Past 5 Days
Digital Brand Media And Marketing Group Inc
Profile
Digital Brand Media and Marketing Group Inc is a company that specializes in providing digital media and marketing services. They create innovative marketing strategies and campaigns for clients to enhance their brand visibility and reach their target audience. Their business model includes offering a wide range of digital marketing services such as social media management, content creation, SEO, and paid advertising to help brands maximize their online presence and drive business growth.
Danaher Corporation operates a diversified business model centered on developing advanced technologies and solutions across multiple sectors, particularly life sciences, diagnostics, dental, and environmental. The company emphasizes continuous innovation and operational excellence, leveraging its proprietary technologies to drive growth and improve efficiency. By strategically acquiring and integrating complementary businesses, Danaher enhances its product offerings while expanding its global market presence.
Sources:
908 Devices inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on 908 Devices inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
